Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px
Document › Details

Sanofi S.A.. (4/27/18). "Press Release: First-quarter 2018 Business EPS up 1.4% at CER". Paris.

Organisations Organisation Sanofi S.A. (EURONEXT: SAN, NYSE: SNY)
  Group Sanofi (Group) [since May 2011]
  Organisation 2 Bioverativ Inc. (Nasdaq: BIVV)
  Group Sanofi (Group) [since May 2011]
Products Product pharmaceutical
  Product 2 Lantus®
Index term Index term Ablynx–Sanofi: investment, 201801–201806 acquisition recommended cash tender offer €3.9b with €45/share
Person Person Brandicourt, Olivier (Sanofi 201508 CEO before CEO of Bayer HealthCare before Pfizer Inc)
     


   
Record changed: 2018-05-01

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

More documents for Sanofi (Group) [since May 2011]


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 600x60px




» top